Clinical Trial Title
RECOVER-AUTONOMIC: A Platform Protocol for Evaluation of Interventions for Autonomic Dysfunction in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)National Clinical Trial Number:
NCT06305780Contact Information
Clinical Trial Protocol Description:
Researchers are studying possible treatments for adults who have Postural Orthostatic Tachycardia Syndrome (POTS) symptoms related to Long COVID. POTS causes a number of autonomic dysfunction symptoms like fast heart rate, dizziness, and fatigue when standing up from sitting or lying down. We want to learn if a study drug and lifestyle changes can improve daily functioning for people with ongoing symptoms after a COVID infection.
Clinical Trial Eligibility Criteria:
In order to participate you must meet the following criteria:
- Are an adult who developed POTS symptoms after getting COVID.
- Do not have an active COVID infection.
- Have 1 or more of the following POTS symptoms when you stand up:
- Fast heart rate
- Dizziness
- Fatigue
This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.
Study Details
Clinical Trial Investigator
James Moy, MD
Contact Information
Minnie Kang
Clinical Trial Location
RUSH University Medical Center